ALXN
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Speculative Growth
# of Employee: 2,924 / Fiscal Year End: 2016-12-31 / Stock Type: Large Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Alexion Pharmaceuticals Inc is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | VRTX | INCY | BMRN | VVUS |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-03-25Quarter566,616k32,939k1,063k159,354k159,354k201,804,k94.20%28.10%28.10%
2014-06-25Quarter512,495k39,626k715k166,495k166,495k201,524,k92.30%32.50%32.50%
2014-09-25Quarter555,146k51,858k655k177,731k177,731k201,313,k90.70%32.00%32.00%
2014-12-25Quarter599,476k49,439k549k153,332k153,332k201,908,k91.80%25.60%25.60%
2015-03-25Quarter600,333k69,399k651k91,323k91,323k202,034,k88.40%15.20%15.20%
2015-06-25Quarter636,210k52,007k3,971k170,215k170,215k204,546,k91.80%26.80%26.80%
2015-09-25Quarter666,637k54,057k19,971k-183,757k-183,757k226,228,k91.90%-27.60%-27.60%
2015-12-25Quarter700,867k57,626k23,151k66,604k66,604k228,308,k91.80%9.50%9.50%
2016-03-25Quarter701,038k58,986k23,890k92,166k92,166k226,873,k91.60%13.10%13.10%
2016-06-25Quarter753,116k60,627k23,793k114,943k114,943k225,756,k91.90%15.30%15.30%
2016-12-25Quarter830,740k67,292k24,510k92,436k92,436k228,320,k91.90%11.10%11.10%
2017-03-25Quarter870m69m24m170m170m226,000,k92.10%19.50%19.50%
2017-06-25Quarter912m84m24m165m165m225,000,k90.80%18.10%18.10%
2017-09-25Quarter859m157m25m78m78m225,000,k81.70%9.10%9.10%
2017-12-25Quarter910,100k144,200k25,400k30,300k30,300k223,600,k84.20%3.30%3.30%
2018-03-25Quarter930,900k91,600k24,100k249,100k249,100k223,700,k90.20%26.80%26.80%
2018-06-25Quarter1,045m95,300k25m-457,400k-457,400k222,600,k90.90%-43.80%-43.80%
2018-09-25Quarter1,026,500k90,600k24,600k330,900k330,900k224,600,k91.20%32.20%32.20%
2018-12-25Quarter1,128,800k96,800k24,500k-45m-45m225,400,k91.40%-4.00%-4.00%
2019-03-25Quarter1,140,400k85,800k19,900k587,900k587,900k225,500,k92.50%51.60%51.60%
2019-06-25Quarter1,203,300k99,200k18,300k459,800k459,800k225,600,k91.80%38.20%38.20%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-03-25Quarter5.95%110.69%-38.76%-42.69%-42.69%0.11%-6.16%-45.91%-45.91%
2015-06-25Quarter24.14%31.24%455.38%2.23%2.23%1.50%-0.54%-17.54%-17.54%
2015-09-25Quarter20.08%4.24%2,949.01%-203.39%-203.39%12.38%1.32%-186.25%-186.25%
2015-12-25Quarter16.91%16.56%4,116.94%-56.56%-56.56%13.08%0.00%-62.89%-62.89%
2016-03-25Quarter16.77%-15.00%3,569.74%0.92%0.92%12.29%3.62%-13.82%-13.82%
2016-06-25Quarter18.38%16.57%499.17%-32.47%-32.47%10.37%0.11%-42.91%-42.91%
2016-12-25Quarter24.62%24.48%22.73%-150.30%-150.30%0.92%0.00%-140.22%-140.22%
2017-03-25Quarter24.13%19.74%3.67%155.24%155.24%-1.01%0.33%105.26%105.26%
2017-06-25Quarter30.09%42.41%0.46%79.02%79.02%-0.83%-0.87%38.17%38.17%
2017-09-25Quarter14.06%158.96%5.07%-32.14%-32.14%-0.33%-11.10%-40.52%-40.52%
2017-12-25Quarter9.55%114.29%3.63%-67.22%-67.22%-2.07%-8.38%-70.27%-70.27%
2018-03-25Quarter7.00%32.75%0.42%46.53%46.53%-1.02%-2.06%37.44%37.44%
2018-06-25Quarter14.58%13.45%4.17%-377.21%-377.21%-1.07%0.11%-341.99%-341.99%
2018-09-25Quarter19.50%-42.29%-1.60%324.23%324.23%-0.18%11.63%253.85%253.85%
2018-12-25Quarter24.03%-32.87%-3.54%-248.51%-248.51%0.81%8.55%-221.21%-221.21%
2019-03-25Quarter22.51%-6.33%-17.43%136.01%136.01%0.80%2.55%92.54%92.54%
2019-06-25Quarter15.15%4.09%-26.80%-200.52%-200.52%1.35%0.99%-187.21%-187.21%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter8,694m13,253m4,559m2,578m823m3,736m1.907.319
2017-03-25Quarter8,856m13,435m4,579m2,733m837m3,742m1.934.306
2017-06-25Quarter8,875m13,489m4,614m2,789m856m3,758m1.923.307
2017-09-25Quarter8,944m13,643m4,699m2,882m972m3,727m1.903.337
2017-12-25Quarter8,893,100k13,583,300k4,690,200k2,953,900k952,500k3,737,700k1.896.322
2018-03-25Quarter9,112,700k13,830,200k4,717,500k3,152m942m3,775,500k1.932.299
2018-06-25Quarter8,767,400k13,490,400k4,723m2,836,100k1,044,400k3,678,600k1.856.368
2018-09-25Quarter9,169,700k13,843,600k4,673,900k3,248,400k1,027,400k3,646,500k1.962.316
2018-12-25Quarter9,165,300k13,931,900k4,766,600k3,385m1,174m3,592,600k1.923.347
2019-03-25Quarter9,706,600k13,999,600k4,293m3,650,600k943,800k3,349,200k2.261.259

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter2.29%2.49%2.88%14.58%15.74%0.05%-0.58%0.94%
2018-03-25Quarter2.90%2.94%3.02%15.33%12.54%0.90%-0.10%-2.29%
2018-06-25Quarter-1.21%0.01%2.36%1.69%22.01%-2.11%-3.48%19.87%
2018-09-25Quarter2.52%1.47%-0.53%12.71%5.70%-2.16%3.10%-6.23%
2018-12-25Quarter3.06%2.57%1.63%14.59%23.25%-3.88%1.42%7.76%
2019-03-25Quarter6.52%1.22%-9.00%15.82%0.19%-11.29%17.03%-13.38%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note